1
|
Malov SI, Malov IV, Kuvshinov AG, Marche PN, Decaens T, Macek-Jilkova Z, Yushchuk ND. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C. Sovrem Tekhnologii Med 2021; 13:27-33. [PMID: 34513063 PMCID: PMC8353694 DOI: 10.17691/stm2021.13.1.03] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2020] [Indexed: 12/24/2022] Open
Abstract
The aim of the study was to identify the most effective serum tumor markers for early diagnosis of hepatocellular carcinoma based on the combination of diagnostic characteristics and correlations.
Collapse
Affiliation(s)
- S I Malov
- Associate Professor, Department of Infectious Diseases, Irkutsk State Medical University, 1 Krasnogo Vosstaniya St., Irkutsk, 664003, Russia, Senior Researcher, Central Scientific Research Laboratory, Irkutsk State Medical Academy of Post-Graduate Education, a Branch of the Russian Medical Academy of Continuing Professional Education, 100 Yubileyny Microdistrict, Irkutsk, 664049, Russia
| | - I V Malov
- Professor, Head of the Department of Infectious Diseases, Irkutsk State Medical University, 1 Krasnogo Vosstaniya St., Irkutsk, 664003, Russia
| | - A G Kuvshinov
- Assistant, Department of Oncology and Radiation Therapy, Irkutsk State Medical University, 1 Krasnogo Vosstaniya St., Irkutsk, 664003, Russia
| | - P N Marche
- Professor, Vice Director of Research Center, Institute for Advanced Biosciences, Site Santé, Allée des Alpes, La Tronche, 38700, France
| | - T Decaens
- Professor, Research Director, Laboratory Head of Department of Hepatology and Gastroenterology, Centre Hospitalier Universitaire Grenoble Alpes, Avenue Maquis du Grésivaudan, La Tronche, 38700, France
| | - Z Macek-Jilkova
- Researcher, Department of Hepatology and Gastroenterology, Centre Hospitalier Universitaire Grenoble Alpes, Avenue Maquis du Grésivaudan, La Tronche, 38700, France
| | - N D Yushchuk
- Professor, Academician of the Russian Academy of Sciences, Head of the Department of Infectious Diseases and Epidemiology, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, 20/1 Delegatskaya St., Moscow, 127473, Russia
| |
Collapse
|
2
|
Macek-Jilkova Z, Malov SI, Kurma K, Charrat C, Decaens T, Peretolchina NP, Marche PN, Malov IV, Yushchuk ND. Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer. Bull Exp Biol Med 2021; 170:340-344. [PMID: 33452981 DOI: 10.1007/s10517-021-05063-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Indexed: 12/31/2022]
Abstract
We evaluated the possibility of using an experimental model of hepatocellular carcinoma to study oncomarkers of primary liver cancer and compared the diagnostic efficacy of alpha-fetoprotein and osteopontin in the experiment and in clinical practice. Experimental studies were performed on a model of hepatocellular carcinoma induced by administration of diethyl nitrosamine to Fisher-344 rats. In addition, the levels of α-fetoprotein and osteopontin were determined in 35 patients with hepatocellular carcinoma detected at stages I-II according to TNM classification. The proposed model of liver cancer in rats reflects the sequence of stages characteristic of hepatocellular carcinoma in humans: liver fibrosis-cirrhosis-cancer. This model is applicable for the study of tumor markers at the early stage of tumor development. Osteopontin was found to have a more powerful diagnostic potential then alpha-fetoprotein.
Collapse
Affiliation(s)
- Z Macek-Jilkova
- Clinique Universitaire d'Hépato-gastroentérologie, Pôle Digidune, CHU Grenoble Alpes, La Tronche, France.,Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - S I Malov
- Irkutsk State Medical University, Ministry of Health of the Russian Federation, Irkutsk, Russia.
| | - K Kurma
- Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - C Charrat
- Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - T Decaens
- Clinique Universitaire d'Hépato-gastroentérologie, Pôle Digidune, CHU Grenoble Alpes, La Tronche, France.,Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - N P Peretolchina
- Irkutsk State Medical University, Ministry of Health of the Russian Federation, Irkutsk, Russia
| | - P N Marche
- Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - I V Malov
- Irkutsk State Medical University, Ministry of Health of the Russian Federation, Irkutsk, Russia
| | - N D Yushchuk
- A. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|
3
|
Malov SI, Malov IV, Dvornichenko VV, Rasulov RI, Kuvshinov AG, Marche PN, Decaens T, Macek-Jilkova Z, Yushchuk ND. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]. Klin Lab Diagn 2019; 64:607-612. [PMID: 31742954 DOI: 10.18821/0869-2084-2019-64-10-607-612] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2019] [Accepted: 09/20/2019] [Indexed: 12/16/2022]
Abstract
Liver cirrhosis in the outcome of hepatitis C is the leading cause of hepatocellular carcinoma (HCC) in the world. Early diagnosis and timely treatment of HCC are important for reducing mortality and increasing life expectancy of patients with hepatocellular carcinoma. To assess the risk of HCC, the definition of alpha-fetoprotein (AFP) in the blood is most widely used, but low sensitivity limits its diagnostic value. In 2012, a new HCC biomarker - osteopontin (OPN), which is a secreted phosphoprotein that has a high affinity for integrins was proposed. The level of acute renal failure begins to rise in the early stages of malignancy, before the period of HCC detection by imaging methods, and has significantly better sensitivity than AFP. The purpose of this study is to evaluate the diagnostic efficacy of the combined determination of alpha-fetoprotein and osteopontin in prospective monitoring of patients with chronic hepatitis C in the advanced phase of liver fibrosis. Monitoring of 588 patients with hepatitis C was carried out from February 2013 to February 2019. HCC was detected in 55 of them (2.6% per year). The combination of 2 biomarkers showed better diagnostic efficacy than alpha-fetoprotein and osteopontin separately: AUC 0.85 (95% CI 0.80-0.90) versus AUC 0.63 (95% CI 0.57-0, 70) and AUC 0.82 (95% CI 0.77-0.88), respectively. This combination showed a sensitivity of 85.5% and made it possible to diagnose HCC with a prognostic level of a positive result of 72.3% at 19,4±0,8 weeks before the diagnosis was confirmed by instrumental imaging methods (ultrasound, MRI, CT). In the combined variant, ARF made the greatest contribution to the increase in diagnostic efficacy (AUC). At an early and very early stage of HCC development, isolated HCC elevations were found in only 5.4% of patients. Conclusion: the combined use of alphafetoprotein and osteopontin as a diagnostic panel can be recommended for monitoring patients with liver cirrhosis in the outcome of hepatitis C and predicting HCC at an early stage of development.
Collapse
Affiliation(s)
- S I Malov
- Irkutsk State Medical university, 664003, Irkutsk, Russia.,Irkutsk State Medical Academy of Postgraduate education, 664049, Irkutsk, Russia
| | - I V Malov
- Irkutsk State Medical university, 664003, Irkutsk, Russia
| | - V V Dvornichenko
- Irkutsk State Medical university, 664003, Irkutsk, Russia.,Irkutsk State Medical Academy of Postgraduate education, 664049, Irkutsk, Russia
| | - R I Rasulov
- Irkutsk State Medical Academy of Postgraduate education, 664049, Irkutsk, Russia
| | - A G Kuvshinov
- Irkutsk State Medical university, 664003, Irkutsk, Russia
| | - P N Marche
- Institute for Advanced Biosciences, Research Center Inserm U1209, CNRS 5309, Univ. Grenoble-Alpes, 38700, La Tronche, France
| | - T Decaens
- Institute for Advanced Biosciences, Research Center Inserm U1209, CNRS 5309, Univ. Grenoble-Alpes, 38700, La Tronche, France
| | - Z Macek-Jilkova
- Institute for Advanced Biosciences, Research Center Inserm U1209, CNRS 5309, Univ. Grenoble-Alpes, 38700, La Tronche, France
| | - N D Yushchuk
- Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, 127473, Moscow, Russia
| |
Collapse
|
4
|
Malov S, Malov I, Dvornichenko V, Marche P, Decaens T, Macek-Jilkova Z, Yushchuk N. Biomarkers in Diagnosis and Prediction of Hepatocellular Carcinoma Recurrence (Review). Sovrem Tekhnologii Med 2019. [DOI: 10.17691/stm2019.11.2.23] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|